Vincent Lepreux | Investment Principal
Debiopharm Innovation Fund

Vincent Lepreux is the Investment Principal at Debiopharm Innovation Fund, focusing on early-stage digital health and techbio startups. He has over four years of experience in this role, emphasizing investments in digital health to improve patient care pathways and transform pharmaceutical R&D. Prior to this, Vincent accrued a decade of expertise in Financial Advisory and corporate development, evaluating, advising, and helping companies with their external growth and development plans. He holds a Master's Degree in Corporate Finance. Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, provides funding and guidance for companies with an ambition to improve the patient journey and transform pharmaceutical R&D. Since 2017, Debiopharm has invested in 15 AI and digital health companies, typically leading the investment rounds. As of September 2023, Debiopharm Innovation Fund is expanding its footprint through a new Seed financing activity.